Nucor's Q1 2020 earnings were significantly impacted by losses on assets of $287.8 million related to their equity method investment in Duferdofin Nucor S.r.l. Consolidated net earnings were $20.3 million, or $0.07 per diluted share, compared to $501.8 million, or $1.63 per diluted share, for Q1 2019. Net sales decreased by 8% to $5.62 billion compared to $6.10 billion in Q1 2019.
Consolidated net earnings were $20.3 million, or $0.07 per diluted share, including losses on assets.
Net sales decreased 8% to $5.62 billion compared to Q1 2019.
The company expects to report a loss in the second quarter of 2020 due to the COVID-19 pandemic.
Capital expenditure estimate for 2020 was revised down to less than $1.50 billion.
Nucor expects to report a loss in the second quarter of 2020, but anticipates market conditions will bottom in Q2 and return to profitability in the second half of the year.
Visualization of income flow from segment revenue to net income